Hypertension With Negative Metaiodobenzylguanidine Scintigraphy

Hypertension. 2022 Feb;79(2):474-478. doi: 10.1161/HYPERTENSIONAHA.121.18012. Epub 2021 Dec 9.

Antoine-Guy Lopez^{1

2}, Anna F Dominiczak³, Rhian Touyz⁴, Markus Schlaich⁵, Jean-Baptiste de Freminville^{1

6}, Laurence Amar^{1

6}

¹ Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Unité Hypertension Artérielle, Paris, France (A.-G.L., J.-B.d.F., L.A.).
² Normandie Univ, UNIROUEN, INSERM U1239, Rouen University Hospital, Department of Endocrinology, Diabetology and Metabolic Diseases, Rouen, France (A.-G.L.).
³ Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences (A.F.D.), University of Glasgow, United Kingdom.
⁴ Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre (R.T.), University of Glasgow, United Kingdom.
⁵ Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, Royal Perth Hospital Medical Research Foundation, The University of Western Australia, Australia (M.S.).
⁶ Université de Paris, PARCC, INSERM, France (J.-B.d.F., L.A.).

No abstract available

Publication types